Literature DB >> 6755782

Macrophage-mediated destruction of malignant tumor cells and new strategies for the therapy of metastatic disease.

I J Fidler, G Poste.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6755782     DOI: 10.1007/bf00199794

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


× No keyword cloud information.
  36 in total

1.  Inhibition of pulmonary metastasis by intravenous injection of specifically activated macrophages.

Authors:  I J Fidler
Journal:  Cancer Res       Date:  1974-05       Impact factor: 12.701

Review 2.  The implications of tumor heterogeneity for studies on the biology of cancer metastasis.

Authors:  I R Hart; I J Fidler
Journal:  Biochim Biophys Acta       Date:  1981-08-31

3.  In situ activation of murine macrophages by liposomes containing lymphokines.

Authors:  W E Fogler; A Raz; I J Fidler
Journal:  Cell Immunol       Date:  1980-07-15       Impact factor: 4.868

4.  Evidence for mononuclear phagocytes in solid neoplasms and appraisal of their nonspecific cytotoxic capabilities.

Authors:  S W Russell; G Y Gillespie; J L Pace
Journal:  Contemp Top Immunobiol       Date:  1980

5.  Biochemical, morphological, and ultrastructural studies on the uptake of liposomes by murine macrophages.

Authors:  A Raz; C Bucana; W E Fogler; G Poste; I J Fidler
Journal:  Cancer Res       Date:  1981-02       Impact factor: 12.701

Review 6.  The pathogenesis of cancer metastasis.

Authors:  G Poste; I J Fidler
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

7.  Divergent effects of macrophage toxins on growth of primary tumors and lung metastases in mice.

Authors:  A Mantovani; R Giavazzi; N Polentarutti; F Spreafico; S Garattini
Journal:  Int J Cancer       Date:  1980-05-15       Impact factor: 7.396

8.  Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages.

Authors:  I J Fidler; A Raz; W E Fogler; R Kirsh; P Bugelski; G Poste
Journal:  Cancer Res       Date:  1980-12       Impact factor: 12.701

9.  Role of natural killer cells in the destruction of circulating tumor emboli.

Authors:  N Hanna; I J Fidler
Journal:  J Natl Cancer Inst       Date:  1980-10       Impact factor: 13.506

10.  Macrophage content of metastatic and nonmetastatic rodent neoplasms.

Authors:  J E Talmadge; M Key; I J Fidler
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

View more
  34 in total

1.  Inhibition of liver tumor cell colonization in two animal tumor models by lectin blocking with D-galactose or arabinogalactan.

Authors:  J Beuth; H L Ko; V Schirrmacher; G Uhlenbruck; G Pulverer
Journal:  Clin Exp Metastasis       Date:  1988 Mar-Apr       Impact factor: 5.150

2.  Characterization of a recombinant vaccinia virus expressing human melanoma-associated antigen p97.

Authors:  S L Hu; G D Plowman; P Sridhar; U S Stevenson; J P Brown; C D Estin
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

3.  Potentiation of direct antitumor cytotoxicity and production of tumor cytolytic factors in human blood monocytes by human recombinant interferon-gamma and muramyl dipeptide derivatives.

Authors:  S Sone; G Lopez-Berestein; I J Fidler
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

4.  Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and D-galactose.

Authors:  J Beuth; H L Ko; K Oette; G Pulverer; K Roszkowski; G Uhlenbruck
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

5.  Liposome-encapsulated muramyl tripeptide up-regulates monocyte chemotactic and activating factor gene expression in human monocytes at the transcriptional and post-transcriptional levels.

Authors:  T Asano; K Matsushima; E S Kleinerman
Journal:  Cancer Immunol Immunother       Date:  1994-01       Impact factor: 6.968

6.  Influence of adoptively transferred thioglycollate-elicited peritoneal macrophages on metastasis formation in mice with depressed or stimulated NK activity.

Authors:  E Gorelik; R H Wiltrout; M J Brunda; W E Bere; R B Herberman
Journal:  Clin Exp Metastasis       Date:  1985 Apr-Jun       Impact factor: 5.150

7.  Interferon-alpha conjugation to human osteogenic sarcoma monoclonal antibody 791T/36.

Authors:  J M Pelham; J D Gray; G R Flannery; M V Pimm; R W Baldwin
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

8.  Changes in the macrophage content of lung metastases at different stages in tumor growth.

Authors:  P J Bugelski; R L Kirsh; J M Sowinski; G Poste
Journal:  Am J Pathol       Date:  1985-03       Impact factor: 4.307

9.  Review of mifamurtide in the treatment of patients with osteosarcoma.

Authors:  Leo Kager; Ulrike Pötschger; Stefan Bielack
Journal:  Ther Clin Risk Manag       Date:  2010-06-24       Impact factor: 2.423

10.  Anti-(tumor necrosis factor) alters the response of human monocytes to liposomal muramyl tripeptide.

Authors:  M Maeda; T Asano; E S Kleinerman
Journal:  Cancer Immunol Immunother       Date:  1993-08       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.